Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Investigation of pre-existing reactivity to biotherapeutics can uncover potential immunogenic epitopes and predict immunogenicity risk.

Bivi N, Moore T, Rodgers G, Denning H, Shockley T, Swearingen CA, Gelfanova V, Calderon B, Peterson DA, Hodsdon ME, Siegel RW, Higgs RE, Konrad RJ.

MAbs. 2019 Jul;11(5):861-869. doi: 10.1080/19420862.2019.1612699. Epub 2019 May 17.

2.

A quantitative tool to distinguish isobaric leucine and isoleucine residues for mass spectrometry-based de novo monoclonal antibody sequencing.

Poston CN, Higgs RE, You J, Gelfanova V, Hale JE, Knierman MD, Siegel R, Gutierrez JA.

J Am Soc Mass Spectrom. 2014 Jul;25(7):1228-36. doi: 10.1007/s13361-014-0892-1. Epub 2014 May 21.

PMID:
24845350
3.

Epitope mapping of antibodies by mass spectroscopy: a case study.

Obungu VH, Gelfanova V, Huang L.

Methods Mol Biol. 2013;988:291-302. doi: 10.1007/978-1-62703-327-5_18.

PMID:
23475727
4.

Determination of the mechanism of action of anti-FasL antibody by epitope mapping and homology modeling.

Obungu VH, Gelfanova V, Rathnachalam R, Bailey A, Sloan-Lancaster J, Huang L.

Biochemistry. 2009 Aug 4;48(30):7251-60. doi: 10.1021/bi900296g.

PMID:
19588926
5.

Macrophage-mediated degradation of beta-amyloid via an apolipoprotein E isoform-dependent mechanism.

Zhao L, Lin S, Bales KR, Gelfanova V, Koger D, Delong C, Hale J, Liu F, Hunter JM, Paul SM.

J Neurosci. 2009 Mar 18;29(11):3603-12. doi: 10.1523/JNEUROSCI.5302-08.2009.

6.

Proteomics of cerebrospinal fluid: methods for sample processing.

Hale JE, Gelfanova V, You JS, Knierman MD, Dean RA.

Methods Mol Biol. 2008;425:53-66. doi: 10.1007/978-1-60327-210-0_5.

PMID:
18369886
7.

Label-free LC-MS method for the identification of biomarkers.

Higgs RE, Knierman MD, Gelfanova V, Butler JP, Hale JE.

Methods Mol Biol. 2008;428:209-30.

PMID:
18287776
8.

Quantitative analysis of amyloid-beta peptides in cerebrospinal fluid using immunoprecipitation and MALDI-Tof mass spectrometry.

Gelfanova V, Higgs RE, Dean RA, Holtzman DM, Farlow MR, Siemers ER, Boodhoo A, Qian YW, He X, Jin Z, Fisher DL, Cox KL, Hale JE.

Brief Funct Genomic Proteomic. 2007 Jun;6(2):149-58. Epub 2007 Jun 20.

PMID:
17584762
9.

Identifying pharmacodynamic protein markers of centrally active drugs in humans: a pilot study in a novel clinical model.

Patil ST, Higgs RE, Brandt JE, Knierman MD, Gelfanova V, Butler JP, Downing AM, Dorocke J, Dean RA, Potter WZ, Michelson D, Pan AX, Jhee SS, Hale JE.

J Proteome Res. 2007 Mar;6(3):955-66. Epub 2007 Jan 23.

PMID:
17243662
10.

Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry.

Oe T, Ackermann BL, Inoue K, Berna MJ, Garner CO, Gelfanova V, Dean RA, Siemers ER, Holtzman DM, Farlow MR, Blair IA.

Rapid Commun Mass Spectrom. 2006;20(24):3723-35.

PMID:
17117458
11.

Quantitative determination of peptides using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Gutierrez JA, Dorocke JA, Knierman MD, Gelfanova V, Higgs RE, Koh NL, Hale JE.

Biotechniques. 2005 Jun;Suppl:13-7.

PMID:
16528911
12.

Comprehensive label-free method for the relative quantification of proteins from biological samples.

Higgs RE, Knierman MD, Gelfanova V, Butler JP, Hale JE.

J Proteome Res. 2005 Jul-Aug;4(4):1442-50.

PMID:
16083298
13.

The impact of blood contamination on the proteome of cerebrospinal fluid.

You JS, Gelfanova V, Knierman MD, Witzmann FA, Wang M, Hale JE.

Proteomics. 2005 Jan;5(1):290-6.

PMID:
15672452
14.
15.

Application of proteomics for discovery of protein biomarkers.

Hale JE, Gelfanova V, Ludwig JR, Knierman MD.

Brief Funct Genomic Proteomic. 2003 Oct;2(3):185-93. Review.

PMID:
15239922
16.

Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Abeta42 by inhibiting Rho.

Zhou Y, Su Y, Li B, Liu F, Ryder JW, Wu X, Gonzalez-DeWhitt PA, Gelfanova V, Hale JE, May PC, Paul SM, Ni B.

Science. 2003 Nov 14;302(5648):1215-7.

17.
18.

Expression of cytolethal distending toxin and hemolysin is not required for pustule formation by Haemophilus ducreyi in human volunteers.

Young RS, Fortney KR, Gelfanova V, Phillips CL, Katz BP, Hood AF, Latimer JL, Munson RS Jr, Hansen EJ, Spinola SM.

Infect Immun. 2001 Mar;69(3):1938-42.

19.

IL-15 promotes survival but not effector function differentiation of CD8+ TCRalphabeta+ intestinal intraepithelial lymphocytes.

Lai YG, Gelfanov V, Gelfanova V, Kulik L, Chu CL, Jeng SW, Liao NS.

J Immunol. 1999 Dec 1;163(11):5843-50.

20.

Cytolethal distending toxin of Haemophilus ducreyi induces apoptotic death of Jurkat T cells.

Gelfanova V, Hansen EJ, Spinola SM.

Infect Immun. 1999 Dec;67(12):6394-402.

21.

Modulation of cytokine responses of murine CD8+ alphabeta intestinal intraepithelial lymphocytes by IL-4 and IL-12.

Gelfanova V, Lai Y, Gelfanov V, Tzou S, Tu Y, Liao N.

J Biomed Sci. 1999 Jul-Aug;6(4):269-76.

PMID:
10420084
23.

Differential requirement of CD28 costimulation for activation of murine CD8+ intestinal intraepithelial lymphocyte subsets and lymph node cells.

Gelfanov V, Lai YG, Gelfanova V, Dong JY, Su JP, Liao NS.

J Immunol. 1995 Jul 1;155(1):76-82.

PMID:
7602124

Supplemental Content

Loading ...
Support Center